Latest Asx News

Pivotal Metals Limited has updated its exploration insights on high-grade gold targets within its Lorraine project in Quebec, revealing a broad, largely unexplored gold corridor and outlining plans for an aggressive field program.

Invert Graphite has completed significant acquisitions including South Australian exploration licences and appointed a new CEO and board members, setting the stage for its next growth phase.

Elph Investments has raised and finalised its off-market takeover bid for Engenco Limited shares at $0.31 per share, applying to all shareholders including those who already accepted. This move signals a decisive step in the ongoing acquisition process.

Keybridge Capital has lodged a formal complaint with the Takeovers Panel, alleging improper dilution of its voting power in Yowie Group via the HHY Fund ahead of a pivotal shareholder meeting.

QuickFee Limited reports mixed Q4 FY25 results with solid growth in US Pay Now and Australian Finance, offset by a significant US Finance decline due to credit impairment. The company completes a major refinancing and capital raise while maintaining FY25 earnings guidance.

QuickFee Limited has launched a A$1.5 million capital raising to fund expansion of its loan books in the US and Australia, following a quarter of record revenue and positive earnings before tax. The fintech also completed a major refinancing and revised its earnings guidance due to a credit impairment provision.

QuickFee Limited has completed a significant A$118 million debt refinancing and successfully raised A$1.25 million through a share placement, alongside announcing a new Share Purchase Plan to support its expansion in the US and Australian markets.

OncoSil Medical has launched a Security Purchase Plan offering discounted shares and free options to eligible shareholders, aiming to accelerate commercialization of its pancreatic cancer treatment device.

Anax Metals has issued a detailed clarification on its recent $3.3 million convertible note placement with Mineral Development Partners, addressing inconsistencies in shareholder approval disclosures and announcing strengthened compliance measures.

Vertex Minerals confirms fully developed, accessible stope blocks at its Reward Mine, featuring a high-grade inferred resource that promises to accelerate underground production start-up.

ClearVue Technologies’ subsidiary OptiCrop has secured its inaugural commercial project, an $80,000 greenhouse installation leveraging proprietary ground-source heat exchange technology. This milestone underscores ClearVue’s strategic expansion into sustainable protected cropping and greenhouse agriculture.

Chimeric Therapeutics has secured FDA Fast Track designation for its CHM CDH17 CAR-T therapy targeting gastroenteropancreatic neuroendocrine tumours, accelerating its path toward regulatory approval and patient access.